Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Anglaret

Showing results (101-110 of 161) with videos related to

Pageof 17
Sort By:
Journal of the International AIDS Society|July 3, 2014
Decrease in sexual risk behaviours after early initiation of antiretroviral therapy: a 24-month prospective study in Côte d'IvoireKévin Jean, Delphine Gabillard, Raoul Moh, et al.
The American Journal of Tropical Medicine and Hygiene|November 17, 2017
Clinical Outcomes during Treatment Interruptions in Human Immunodeficiency Virus-Hepatitis B Virus Co-infected Patients from Sub-Saharan AfricaAnders Boyd, Laura Houghtaling, Raoul Moh, et al.
Plos One|October 21, 2014
Quantiferon-TB Gold: performance for ruling out active tuberculosis in HIV-infected adults with high CD4 count in Côte d'Ivoire, West AfricaChristine Danel, Mathieu Kabran, André Inwoley, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 4, 2016
Laboratory Monitoring of Antiretroviral Therapy for HIV Infection: Cost-Effectiveness and Budget Impact of Current and Novel StrategiesEric N Ouattara, Marion Robine, Serge P Eholié, et al.
Antiviral Therapy|December 3, 2003
Medium-term survival, morbidity and immunovirological evolution in HIV-infected adults receiving antiretroviral therapy, Abidjan, Côte d'IvoireCatherine Seyler, Xavier Anglaret, Nicole Dakoury-Dogbo, et al.
Plos One|June 28, 2019
Cost-effectiveness and budget impact of immediate antiretroviral therapy initiation for treatment of HIV infection in Côte d'Ivoire: A model-based analysisEric N Ouattara, Rachel L MacLean, Christine Danel, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 13, 2024
Rapid decrease in IL-1Ra and IP-10 plasma levels following tuberculosis treatment initiationPolidy Pean, Roseline Affi, Corine Chazalon, et al.
CPT: Pharmacometrics & Systems Pharmacology|March 22, 2020
Modeling Favipiravir Antiviral Efficacy Against Emerging Viruses: From Animal Studies to Clinical TrialsVincent Madelain, France Mentré, Sylvain Baize, et al.
Annals of Internal Medicine|August 29, 2017
Do Less Harm: Evaluating HIV Programmatic Alternatives in Response to Cutbacks in Foreign AidRochelle P Walensky, Ethan D Borre, Linda-Gail Bekker, et al.
BMJ Open|December 3, 2020
Simplifying and optimising management of acute malnutrition in children aged 6 to 59 months: study protocol for a community-based individually randomised controlled trial in Kasaï, Democratic Republic of CongoCécile Cazes, Kevin Phelan, Victoire Hubert, et al.
Pageof 17

Showing results (101-110 of 161) with videos related to

Sort By:
Pageof 17
Journal of the International AIDS Society|July 3, 2014
Decrease in sexual risk behaviours after early initiation of antiretroviral therapy: a 24-month prospective study in Côte d'IvoireKévin Jean, Delphine Gabillard, Raoul Moh, et al.
The American Journal of Tropical Medicine and Hygiene|November 17, 2017
Clinical Outcomes during Treatment Interruptions in Human Immunodeficiency Virus-Hepatitis B Virus Co-infected Patients from Sub-Saharan AfricaAnders Boyd, Laura Houghtaling, Raoul Moh, et al.
Plos One|October 21, 2014
Quantiferon-TB Gold: performance for ruling out active tuberculosis in HIV-infected adults with high CD4 count in Côte d'Ivoire, West AfricaChristine Danel, Mathieu Kabran, André Inwoley, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 4, 2016
Laboratory Monitoring of Antiretroviral Therapy for HIV Infection: Cost-Effectiveness and Budget Impact of Current and Novel StrategiesEric N Ouattara, Marion Robine, Serge P Eholié, et al.
Antiviral Therapy|December 3, 2003
Medium-term survival, morbidity and immunovirological evolution in HIV-infected adults receiving antiretroviral therapy, Abidjan, Côte d'IvoireCatherine Seyler, Xavier Anglaret, Nicole Dakoury-Dogbo, et al.
Plos One|June 28, 2019
Cost-effectiveness and budget impact of immediate antiretroviral therapy initiation for treatment of HIV infection in Côte d'Ivoire: A model-based analysisEric N Ouattara, Rachel L MacLean, Christine Danel, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 13, 2024
Rapid decrease in IL-1Ra and IP-10 plasma levels following tuberculosis treatment initiationPolidy Pean, Roseline Affi, Corine Chazalon, et al.
CPT: Pharmacometrics & Systems Pharmacology|March 22, 2020
Modeling Favipiravir Antiviral Efficacy Against Emerging Viruses: From Animal Studies to Clinical TrialsVincent Madelain, France Mentré, Sylvain Baize, et al.
Annals of Internal Medicine|August 29, 2017
Do Less Harm: Evaluating HIV Programmatic Alternatives in Response to Cutbacks in Foreign AidRochelle P Walensky, Ethan D Borre, Linda-Gail Bekker, et al.
BMJ Open|December 3, 2020
Simplifying and optimising management of acute malnutrition in children aged 6 to 59 months: study protocol for a community-based individually randomised controlled trial in Kasaï, Democratic Republic of CongoCécile Cazes, Kevin Phelan, Victoire Hubert, et al.
Pageof 17